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Introduction
Embryonic development comprises a series of coordinated
cellular events that together produce the mature organism. The
cytoskeleton plays a crucial role in many of these processes by
directing cell behaviour during development. The Rho family
of small GTPases, or G proteins, are key regulators of the actin
cytoskeleton. In fibroblasts, for example, Rho stimulates the
assembly of contractile acto-myosin filaments and associated
focal adhesion complexes (Ridley and Hall, 1992), Rac induces
the formation of lamellipodia and membrane ruffles (Ridley et
al., 1992), whereas CDC42 induces filopodia (Kozma, 1995).
Many studies have since confirmed the importance of Rho
family proteins as molecular switches that control a wide range
of cellular processes including shape change, adhesion and cell
cycle progression (Hall, 1998).
The functional activity of the Rho family of small GTPases
is regulated in vivo by proteins that control their GTP/GDP
bound state. Guanine nucleotide exchange factors (GEFs)
activate G proteins by catalysing the exchange of bound GDP
for GTP, while GTPase-activating proteins (GAPs), inactivate
G proteins by increasing their low intrinsic GTPase activity
(Whitehead et al., 1997; Zalcman et al., 1999). In the active
GTP-bound state, conformational changes allow the G protein
to interact with downstream effectors and to generate a
response. Members of a third group of regulatory proteins, the
guanine nucleotide dissociation inhibitors (GDIs), bind G
proteins and maintain them in an inactive soluble state by
inhibiting the exchange of GDP for GTP and sequestering them
from membranes (Zalcman et al., 1999).
In Drosophila melanogaster, seven Rho family members
have been identified: RHO1 (RhoA), Rho-like (RhoL), RAC1,
RAC2, CDC42, MIG2-like (MTL) and RhoBTB (Hakeda-
Suzuki et al., 2002; Hariharan et al., 1995; Luo et al., 1994;
Murphy and Montell, 1996). Phenotypic analysis of mutant
alleles and of the effect of expressing dominant negative and
constitutively active forms of these proteins have suggested
roles in a wide range of developmental processes that require
dynamic actin cytoskeleton reorganisation. During Drosophila
oogenesis, for example, CDC42 and RhoL are thought to be
important for the maintenance of the actin-rich ring canals that
connect nurse cells and the oocyte, whereas RAC1 appears to
be required throughout migration of the somatic border cells
(Murphy and Montell, 1996). Reducing RHO1 levels affects
the organisation of the actin cytostructure of egg chambers as
well as ring canal morphology (Magie et al., 1999).
Embryogenesis also involves numerous Rho family
Drosophila pebble (pbl) encodes a Rho-family GTP
exchange factor (GEF) required for cytokinesis. The
accumulation of high levels of PBL protein during
interphase and the developmentally regulated expression of
pbl in mesodermal tissues suggested that the primary
cytokinetic mutant phenotype might be masking other
roles. Using various muscle differentiation markers, we
found that Even skipped (EVE) expression in the dorsal
mesoderm is greatly reduced in pbl mutant embryos. EVE
expression in the dorsalmost mesodermal cells is induced
in response to DPP secreted by the dorsal epidermal cells.
Further analysis revealed that this phenotype is likely to be
a consequence of an earlier defect. pbl mutant mesodermal
cells fail to undergo the normal epithelial-mesenchymal
transition (EMT) and dorsal migration that follows ventral
furrow formation. This phenotype is not a secondary
consequence of failed cytokinesis, as it is rescued by a
mutant form of pbl that does not rescue the cytokinetic
defect. In wild-type embryos, newly invaginated cells at
the lateral edges of the mesoderm extend numerous
protrusions. In pbl mutant embryos, however, cells appear
more tightly adhered to their neighbours and extend very
few protrusions. Consistent with the dependence of the
mesoderm EMT and cytokinesis on actin organisation, the
GTP exchange function of the PBL RhoGEF is required for
both processes. By contrast, the N-terminal BRCT domains
of PBL are required only for the cytokinetic function of
PBL. These studies reveal that a novel PBL-mediated
intracellular signalling pathway operates in mesodermal
cells during the transition from an epithelial to migratory
mesenchymal morphology during gastrulation.
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functions. During cellularisation, the inhibition of Rho
function or activation of CDC42 disrupts the actomyosin
cytoskeleton, halting cellularisation and embryogenesis
(Crawford et al., 1998). The loss of RHO1 activity during
dorsal closure results in abnormal cell shape changes along the
dorsal midline, although closure does occur (Magie et al.,
1999), whereas embryos mutant for Rac1, Rac2 and Mtl do not
complete dorsal closure, presumably owing to the lack of F-
actin at the leading epidermal edge (Hakeda-Suzuki et al.,
2002). Finally, numerous studies have shown that Rho family
members play a crucial role in Drosophila neurogenesis and
muscle development (Hakeda-Suzuki et al., 2002; Hassan and
Vaessin, 1996; Lee and Luo, 1999; Lee and Luo, 2001; Lee et
al., 2000; Luo et al., 1994; Ng et al., 2002). RHO1 is necessary
for neuroblast proliferation and for limiting dendrite growth
(Lee et al., 2000), whereas axon outgrowth requires low levels
of Rac activity (Hakeda-Suzuki et al., 2002; Lee et al., 2000).
The expression of dominant-negative and constitutively active
Rac1 or Cdc42 in the mesoderm blocks myoblast fusion (Luo
et al., 1994), and little or no myoblast fusion occurs in either
a Rac1 Rac2 double mutant or Rac1 Rac2 Mtl triple mutant
embryos (Hakeda-Suzuki et al., 2002).
Activation of different Rho family members in specific
tissues and subcellular locations is regulated by the activity
of an even larger family of RhoGEFs and GAPs. Seven
Drosophila Rho family regulators have been studied to
date: RhoGEF2, RhoGEF3, GEF64C, Pebble (PBL), Trio,
RnRacGAP and RacGAP50C (Barrett et al., 1997; Hacker
and Perrimon, 1998; Debant et al., 1996; Guichard et al.,
1997; Hicks et al., 2001; Prokopenko et al., 1999; Somers and
Saint, 2003). RhoGEF2 is required for gastrulation (Barrett
et al., 1997; Hacker and Perrimon, 1998), Pebble and
RacGAP50C are required for cytokinesis (Prokopenko et al.,
1999; Somers and Saint, 2003), whereas GEF64C and Trio
are necessary for neurogenesis (Bashaw et al., 2001; Bateman
et al., 2000).
Pebble (PBL), a putative Rho GTP exchange factor
(RhoGEF), is required specifically for the cytokinesis phase
of the cell cycle (Hime and Saint, 1992; Lehner, 1992;
Prokopenko et al., 1999). In pbl mutant embryos, cells fail to
divide at cycle 14 of mitosis resulting in embryonic lethality
(Hime and Saint, 1992; Lehner, 1992). Although the
cytokinetic role of PBL and its mammalian orthologue, the
proto-oncogene ECT2, has been the subject of considerable
analysis (O’Keefe et al., 2001; Somers and Saint, 2003;
Tatsumoto et al., 1999), some aspects of the pattern of
accumulation of PBL, such as the high level of protein in
interphase nuclei and the tissue-specific expression patterns
during development (Prokopenko et al., 2000) suggested that
PBL might play roles in processes other than cytokinesis. We
show here that, in addition to a failure in cytokinesis, pbl
mutants display a defect in the epithelial to mesenchymal
transition (EMT) during mesoderm development. The EMT is
a general term given to the process by which cells in an
epithelium lose their contacts with neighbouring cells and
adopt a migratory mesenchymal morphology. An EMT is not
a single event. Rather, it is a series of coordinated changes in
cell-cell adhesion, cell-matrix interactions and cytoskeletal
organisation. The mesodermal EMT occurs in wild-type
embryos immediately after invagination, when the mesodermal
cells dissociate from their epithelial neighbours and migrate
dorsally, forming a monolayer over the underlying ectoderm
(Leptin, 1999; Wilson and Leptin, 2000). We show here that
during this process, wild-type mesodermal cells adopt a
migratory morphology, extending protrusions in the direction
of migration. In pbl mutants, mesodermal cells extend fewer
protrusions and fail to migrate correctly. Furthermore, we show
that this phenotype requires the GEF activity of pbl and is not
a secondary consequence of the cytokinetic role of PBL. These
observations identify a novel, PBL-dependent intracellular
signalling pathway required for the transition of mesodermal
cells from an epithelial to a migratory mesenchymal state
during Drosophila embryogenesis.
Materials and methods
Drosophila stocks and crosses
The following mutations and transgenes were used in this study: pbl2,
pbl3, pbl5 (Jurgens et al., 1984; Prokopenko et al., 1999), paired-GAL4
(Brand and Perrimon, 1993), twist-GAL4 (Greig and Akam, 1993),
UAS-pbl3.2 (Prokopenko et al., 1999), UAS-myc-pbl (a construct
encoding a myc-tagged PBL) (L. O’Keefe and R.S., unpublished),
UAS-pbl D BRCT (A. Harley and R.S., unpublished), UAS-pblD DH
(Prokopenko et al., 1999) and UAS-GFP-Actin (Verkhusha et al.,
1999). Expression of all UAS pbl constructs was confirmed by
immunohistochemistry. Stocks were maintained over marked
balancers where necessary.
In situ hybridisation
A 961 bp fragment corresponding to nucleotides 2179-3140 of the pbl
cDNA (CG8114) and the full-length twist cDNA (gift from M. Frasch)
were linearised and labelled with digoxigenin according to the
manufacturer’s protocol (Roche). The labelled probes were hybridised
to embryos collected and fixed using standard methods and detected
as described previously (Tautz and Pfeifle, 1989).
Sectioning of embryos
Stained embryos were dehydrated through an ethanol series to 100%
ethanol. Embryos were then transferred to dry acetone followed by a
1:1 ratio of dry acetone and araldite (ProSciTech). Once the embryos
had equilibrated, the dry acetone and araldite was replaced twice with
araldite alone. The embryos were then orientated for sectioning in
embedding moulds, polymerised at 60°C for 2 days and sectioned on
a microtome (Sorvall). The sections were photographed using a Zeiss
Axioscope and processed using Adobe Photoshop.
Antibody stains
The primary antibodies used were as follows: mouse anti-EVE
(1:450) (Developmental Studies Hybridoma Bank), rabbit anti-
Spectrin (1:50) (gift from D. Branton, Harvard University), mouse
anti-Fasciclin 3 (1:1) (Developmental Studies Hybridoma Bank),
mouse anti-Muscle Myosin heavy chain (MHC) (1:10) (Kiehart and
Feghali, 1986), rabbit anti- b Gal (1:500) (Jackson ImmunoResearch
Laboratories) and rabbit anti-GFP (1:200) (Jackson ImmunoResearch
Laboratories). Secondary antibodies used were goat anti-mouse AP
(1:500), goat anti-rabbit HRP (1:500), goat anti-rabbit Cy5 (1:200)
(Jackson ImmunoResearch Laboratories), goat anti-mouse Alexa 488
(1:200) and goat anti-rabbit Alexa 488 (1:200) (Molecular Probes).
Embryos for fluorescence imaging were stained with Hoechst 33258
(10 m g/ml) to visualise the nuclei. Antibody stains were photographed
using a Zeiss Axioscope or a DeltaVision (Applied Precision)
deconvolution microscopy system and processed using Adobe
Photoshop.
Embryos were stained for F-actin using Phalloidin-TRITC (Sigma).
Phalloidin and anti-GFP stains were imaged using a Leica TCS SP2
Inverted Confocal System. For Fig. 8, heterozygous embryos were
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chosen based on the strength of a fluorescently labelled
marker on the TM3 balancer.
EVE-positive hemisegment counts and
Kolmogorov-Smirnov test
The numbers of EVE-positive hemisegments for the
control and the experimental embryos (n=50) at stage 11
were determined [adapted from Michelson et al.
(Michelson et al., 1998)]. For the analysis, thoracic
segments T1-T3 and abdominal segments A1-A8 on both
sides of the embryo were scored. A hemisegment was
scored as EVE positive if one or more EVE-positive
mesodermal cells were present. The mean and standard
error of the mean (s.e.m.) were calculated for each dataset,
and graphs were drawn using Microsoft Excel. The control
and experimental embryos were compared using a
Kolmogorov-Smirnov test (KS-test) (Conover, 1999) to
determine whether the two datasets differed significantly.
In the KS-test the maximum vertical deviation between the
cumulative distribution functions for the two samples is
calculated to determine whether there is a significant
difference.
Results
pebble expression in the presumptive
mesoderm is developmentally regulated
pebble (pbl), a regulator of the Rho family, has
previously been shown to be expressed in
proliferating tissues, consistent with its role in
cytokinesis (Prokopenko et al., 2000). Some
observations, such as the presence of high levels of
PBL protein in the nuclei of interphase cells,
suggested that the primary cytokinetic phenotype of
pbl mutants could be obscuring other roles for PBL
during Drosophila development. As a first step in
examining this possibility, the pbl expression pattern
was re-analysed by whole-mount in situ
hybridisation with a pbl RNA antisense probe. As
reported previously, pbl mRNA was found to be
present at high levels in pole cells at cellularisation
(Fig. 1A) and zygotic expression was induced during
interphase of cycle 14 (Prokopenko et al., 2000).
However, induction of zygotic expression was not
uniform throughout the embryo. Specifically,
expression was lower in the ventral region of the
blastoderm epithelium than in other parts of the
embryo (Fig. 1B). pbl expression in the presumptive
mesoderm was first observed immediately prior to
invagination (Fig. 1C), the expression pattern
becoming more pronounced and discrete as stage 6
progresses (Fig. 1D,E). After mesoderm
invagination, pbl is strongly expressed in the
invaginated tissue (Fig. 1F).
The majority of EVE-positive mesodermal
cells fail to form in pebble mutant embryos
The mesodermal pattern of expression prompted us
to explore the nature of mesoderm development in pbl mutant
embryos. Mesoderm development is a highly dynamic process
characterised by significant cell shape change and cell
movement. Initially, the mesoderm is defined on the ventral
surface of the blastoderm embryo by the expression of two
zygotic genes, twist (twi) and snail (sna) (Leptin, 1991).
During gastrulation, cells of the mesoderm primordium are
internalised and undergo an epithelial-mesenchymal type of
transition in which the epithelial structure breaks down, the
mesodermal cells dissociate from one another and migrate
Fig. 1. pbl expression in the mesoderm is developmentally regulated. Whole-
mount in situ hybridisation of wild-type embryos with a pbl RNA antisense
probe. (A) During early stage 5, pbl transcripts are restricted to the pole cells.
(B-F) Ventral view. (B) At late stage 5, pbl transcripts are observed on either
side of the presumptive mesoderm. (C) At the onset of gastrulation, pbl
transcripts are evident in the presumptive mesoderm (arrow). (D) This
expression becomes restricted as stage 6 progresses (arrow). (E) pbl transcripts
accumulate in a band of cells at the edge of the invaginating mesoderm
(arrows). (F) As invagination proceeds, pbl transcripts are concentrated in the
ventral furrow (arrow).
Fig. 2. pbl mutant embryos have reduced numbers of EVE-positive mesodermal
cells. (A,B) Anti-Fasciclin 3 stains and (C,D) anti-EVE stains of wild-type (A,C)
and pbl2/pbl3 mutant embryos (B,D). (A) At stage 12 in a wild-type embryo, the
visceral mesoderm is seen as a band of cells running along the anteroposterior
axis (arrow). (B) In a similarly staged pbl2/pbl3 mutant embryo, the visceral
mesoderm is evident, although it is less organised (arrow). (C) At stage 11 in a
wild-type embryo, EVE is expressed in segmentally repeated clusters of dorsal
mesodermal cells. The EVE-expressing neuroblasts are out of focus in this
image. (D) In a similarly staged pbl2/pbl3 mutant embryo, the majority of EVE-
positive mesodermal cells fail to form. One EVE-positive hemisegment can be
seen in this embryo (arrow). Based on their position and morphology, the
remainder of the EVE-expressing cells are neuroblasts (arrowheads).
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dorsally, forming a monolayer over the underlying ectoderm
(Leptin, 1999). Cells in different locations then encounter
intercellular signalling molecules such as Wingless (WG) and
Decapentaplegic (DPP), which induce different subsets of
mesodermal cells to adopt different fates (see Frasch, 1999).
To investigate whether pbl plays a role in mesoderm
development, we used a variety of markers to examine the fate
of different types of mesodermal tissues in pbl mutant
embryos. We used anti-Fasciclin 3 and anti-Muscle Myosin
heavy chain (MHC) to visualise visceral mesoderm and
somatic mesoderm respectively. We also used an anti-Even
skipped (EVE) antibody, which, at stage 11, stains segmentally
repeated clusters of dorsal mesodermal cells, which give rise
to two pericardial cells and two somatic muscles (Frasch, 1987;
Carmena et al., 2002). Anti-EVE also stains a subset of cells
in the CNS (Frasch et al., 1987), but these cells are located
ventrally and are readily distinguishable from the pericardial
cells by their location and morphology.
pbl embryos transheterozygous for the amorphic alleles pbl2
and pbl3 (pbl2/pbl3), were found to develop abnormal visceral
mesoderm (Fig. 2A,B) and somatic musculature (data not
shown). The visceral mesoderm is no longer seen as a
continuous band running along the anterior to posterior axis on
each side of the embryo (Fig. 2B) and the fibres of the somatic
musculature are irregular in structure (data not shown). Anti-
EVE staining revealed a more striking phenotype. The number
of EVE-positive mesodermal cells in pbl2/pbl3 embryos was
dramatically reduced compared with wild-type embryos (Fig.
2C,D). The only cells stained with anti-EVE in many pbl2/pbl3
embryos were neuroblasts, based on their ventral location and
on their morphology (Fig. 2D).
To quantify this result, the number of EVE-positive
hemisegments was examined in stage 11 wild-type and
pbl2/pbl3 embryos. All wild-type embryos examined (n=50)
had 22 EVE-positive hemisegments (Fig. 3A,G). The number
of EVE-positive hemisegments in pbl2/pbl3 embryos ranged
from 0-18, with a mean of 6.99±0.43 (s.e.m.; n=100)
(Fig. 3B,G). Furthermore, the number of EVE-positive
hemisegments in pbl2/pbl3 embryos was found to be
significantly less than the number of EVE-positive
hemisegments in wild-type embryos (P<0.001).
The transition of the mesoderm from epithelium to
migratory mesenchyme is aberrant in pebble mutant
embryos
EVE expression in the mesodermal cells is confined to the
dorsal mesoderm, which is dependent on induction by DPP
secreted by the dorsal ectoderm (Gisselbrecht et al., 1996; Lin
et al., 1999; Shishido et al., 1997). Failure to form EVE-
positive mesodermal cells could result from an inability to read
or transduce the DPP signal. Alternatively, it could result from
a failure of mesodermal cells to migrate dorsally to a position
where they would encounter the DPP signal. To investigate the
latter possibility, the invaginated population of mesodermal
cells in wild-type and pbl mutant embryos was examined by in
situ hybridisation with a full-length twist RNA antisense probe
(Fig. 4A,B).
In late stage 10 wild-type embryos, the mesodermal cells
have migrated to form a uniform layer, such that the dorsalmost
mesodermal cells are adjacent to the dorsalmost ectodermal
cells (Leptin and Grunewald, 1990) (Fig. 4A). In late stage 10
pbl2/pbl3 embryos, the cells do not form a uniform layer and
appear aggregated. Moreover, they fail to migrate to a position
adjacent to the dorsalmost ectodermal cells (Fig. 4B).
To further characterise this defect, embryos were stained for
F-actin and optical cross-sections obtained. In stage 10 wild-
type embryos, the mesodermal cells consistently spread into a
uniform monolayer on the inner surface of the ectoderm (Fig.
4C). Mesodermal cells in the same stage pbl2/pbl3 embryos
were typically less spread out (Fig. 4D,E). There was some
variability in the extent of this phenotype. In some cases, there
was complete failure to dissociate from the aggregation along
the midline (Fig. 4D), while in other cases a relatively uniform
monolayer of binucleate cells developed (data not shown). This
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Fig. 3. The number of EVE-
positive hemisegments is
reduced in pbl mutant
embryos. (A-F) Histograms
of the number of EVE-
positive hemisegments in
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variability correlates with the variability observed
in the number of EVE-positive hemisegments
formed in pbl mutant embryos. Mesodermal cells
in pbl2/pbl3 embryos also appeared less rounded
than control embryos and were tightly packed
(Fig. 4E).
The use of transheterozygous pbl2/pbl3 embryos
in our phenotypic analysis should have avoided
any complications from second site mutations.
However, to confirm that loss of pbl was the cause
of the mesoderm phenotype, we used the
GAL4/UAS system (Brand and Perrimon, 1993)
to rescue the mutant phenotype by expression of
wild-type PBL with the mesodermal-specific
driver twist-GAL4 (twi-GAL4). To distinguish the
mesodermal cells from the adjacent ectoderm, we
co-expressed GFP-Actin and wild-type PBL in a
pbl mutant background. In stage 10 control
pbl2/pbl3 mutant embryos expressing GFP-Actin
(Fig. 4F), mesodermal cells exhibited a similar
phenotype to mesodermal cells examined in
pbl2/pbl3 embryos (Fig. 4D-E). By contrast, in
stage 10 embryos also expressing PBL (Fig. 4G),
mesodermal cells had dissociated and migrated to
form a monolayer over the underlying ectoderm,
similar to that seen in wild-type embryos (Fig.
4A,C). Expression of PBL with twi-GAL4 rescued
cytokinesis in the mesodermal cells, but not in the
ectoderm (Fig. 4G¢ ). These results demonstrate
a cell-autonomous requirement for PBL in
mesodermal cells as they migrate to form a
monolayer. They also show that this process does
not depend on PBL-dependent cytokinesis in the
underlying ectodermal cells.
To further characterise the pbl phenotype, we
used twi-GAL4 driven GFP-Actin to examine the
morphology of migrating mesodermal cells in
stage 8 wild-type and pbl2/pbl3 embryos (Fig. 5).
Embryos expressing GFP-Actin alone appeared to
develop normally and gave rise to viable and
fertile adults. In addition to clearly labelling
cellular protrusions, cytoplasmic GFP-Actin was
excluded from nuclei during interphase, allowing
us to identify cells undergoing mitosis (data not
shown).
In wild-type embryos, mesodermal cells undergo their first
mitotic divisions at early stage 8, shortly after gastrulation
(Bate, 1993; Campos-Ortega and Hartenstein, 1985). The cells
then disaggregate and begin to spread dorsally (Fig. 5B,C),
before undergoing a second round of mitosis at stage 8/9 (Bate,
1993; Campos-Ortega and Hartenstein, 1985). To assess
changes in the morphology of mesodermal cells, we examined
embryos between these two rounds of mitosis (Fig. 5A).
Embryos were oriented so that the leading edge of the
migrating cells was parallel to the microscope stage (Fig. 5B).
In wild-type embryos, migrating mesodermal cells were
polarised, with numerous protrusions evident in the direction
of motion, and a more rounded profile observed on the trailing
side (Fig. 5C). Wild-type cells also appeared to lose their close
association with neighbouring mesodermal cells, with gaps
between cells at the leading edge being common (Fig. 5C).
Similarly, cells further back from the leading edge, which were
not adjacent to epidermal cells (Fig. 5B), appeared rounded
with gaps visible between neighbouring cells (Fig. 5E).
By contrast, mesodermal cells in a pbl2/pbl3 mutant
background had fewer protrusions in the direction of motion,
and appeared to be more closely adhered/associated with
neighbouring mesodermal cells (Fig. 5D). This was
particularly clear for those cells adjacent to the epidermis, but
was also a feature of cells further into the mass of aggregated
mesodermal cells, where cells were less rounded and more
solidly packed together, leaving fewer intercellular gaps (Fig.
5F).
Thus, the failure to form EVE-positive mesodermal cells
in pbl mutants is explained by the failure of pbl-deficient
mesodermal cells to correctly undergo the epithelial-
mesenchymal transition and subsequent dorsal migration that
normally follows invagination.
Fig. 4. pbl mutant embryos have a mesodermal cell migration defect.
(A,B) Transverse sections of in situ hybridisations with a twi antisense RNA probe.
(A) In late stage 10 wild-type embryos, the mesodermal cells have dissociated and
migrated dorsally to form a uniform layer beneath the ectoderm (arrows indicate
dorsalmost mesodermal cells, which lie adjacent to the dorsalmost epidermal cells).
(B) In a similarly staged pbl2/pbl3 mutant embryo, the mesodermal cells appear
aggregated and have failed to complete dorsolateral migration (arrows indicate the
dorsalmost epidermal cells). (C) A stage 10, wild-type embryo stained for F-Actin.
Mesodermal cells have formed a monolayer beneath the ectoderm. (D,E)
Equivalently staged pbl2/pbl3 embryos, in which mesoderm spreading is defective.
(F) A stage 10 pbl2/pbl3 embryo expressing GFP-Actin driven by twi-GAL4
visualised with an anti-GFP antibody. Similar to D,E, the spreading of the
mesoderm is defective. (G) A stage 10, pbl2/pbl3 embryo co-expressing wild-type
PBL and GFP-Actin with twi-GAL4 visualised with an anti-GFP antibody. The
dissociation and migration of the mesodermal cells has been rescued, such that the
mesodermal cells form a uniform layer beneath the ectoderm similar to wild type.
(G ¢ ) The same embryo showing multinucleate cells in the ectoderm (arrows).
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The pebble mesoderm phenotype is not a secondary
consequence of failed cytokinesis
In pbl mutant embryos, cytokinesis fails during the 14th mitotic
cycle, the first cycle that exhibits cytokinesis (Hime and Saint,
1992). As a result, mesodermal cells become multinucleate
during the epithelial-mesenchymal transition and subsequent
migration of mesodermal cells. It was possible therefore,
that the mesoderm phenotypes observed were simply the
consequence of an inability of the large bi- and multi-nucleate
cells to undergo a normal epithelial-mesenchymal transition
and/or migration. To address this possibility and to determine
which domains of PBL were required for the mesodermal EMT
and subsequent EVE-positive mesodermal cell formation, we
used a rescue assay previously developed in our laboratory (L.
O’Keefe and R.S., unpublished) in which alternating stripes of
cells express UAS-pbl constructs under the control of the
embryonic driver paired-GAL4 (prd-GAL4). This assay has the
advantage of having internal control stripes that show the pbl
mutant phenotype, even when the phenotype of the alternating
stripes is modified by expression of the construct. Expression
of wild-type PBL with a prd-GAL4 driver in a pbl mutant
background results in stripes of rescue of the cytokinetic
phenotype, which can be visualised in the epidermis by anti-
Spectrin staining (L. O’Keefe and R.S., unpublished) (see Fig.
6E,G).
Expression of wild-type PBL using the prd-GAL4 driver was
able to rescue the number of EVE-positive hemisegments in
pbl2/pbl3 embryos (Fig. 6A). The number of EVE-positive
hemisegments in UAS-myc-pbl, pbl3/prd-GAL4, pbl2 embryos
ranged from 7-22, with a mean of 15.37±0.51 (n=60) (Fig.
3D,G). This was significantly greater (P<0.001) than the
number of EVE-positive hemisegments in pbl2/pbl3 embryos.
At its N terminus, PBL contains two BRCT (BRCA1 C-
terminal) domains. BRCT domains are found in the familial
breast cancer tumour suppressor gene, BRCA1, and in many
other proteins involved in DNA damage sensing and repair (Bork
et al., 1997; Callebaut and Mornon, 1997). The N-terminal
BRCT domain contains an extended region of homology we
have named the RadECl domain (Somers and Saint, 2003).
prd-GAL4 driven expression of a construct, termed
pblD BRCT, lacking the majority of the RadECl region and the
two consensus BRCT domains (Fig. 6I), failed to rescue
cytokinesis in pbl mutant embryos (A. Harley and R.S.,
unpublished) (Fig. 6F,H). By contrast, the EVE-positive
mesodermal cell phenotype in pbl mutant embryos was rescued
(Fig. 6B,D). The number of EVE-positive hemisegments in
UAS-pblD BRCT, pbl3/prd-GAL4, pbl2 embryos ranged from 4-
22, with a mean of 16.12±0.39 (n=86) (Fig. 3E,G). Again, this
was significantly greater (P<0.001) than the number of EVE-
positive hemisegments in pbl2/pbl3 embryos.
To further characterise the effect of PBLD BRCT on
mesodermal cells we used the twi-GAL4 driver to express both
PBLD BRCT and GFP-Actin in a pbl2/pbl3 mutant background.
As expected, expression of PBL D BRCT in migrating
mesodermal cells did not rescue cytokinesis (Fig. 6K,L). It did,
however, substantially shift the mesodermal cell morphology
towards wild type, with binucleate cells often exhibiting
numerous protrusions (Fig. 6J,L) and appearing more rounded
and less closely adhered to each other (Fig. 6K). These data
show that the failure in cytokinesis and the failure in mesoderm
development in pbl mutants are separable.
The RhoGEF function of Pebble is required for
normal mesoderm development
Mesodermal cell migration is a dynamic process that requires
significant actin cytoskeleton rearrangements. The Rho family
of small GTPases and their regulators are known to be required
for numerous actin-based processes during Drosophila
Development 131 (11) Research article
Fig. 5. The morphology of mesodermal cells is defective in
pbl mutant embryos. Control (A-C,E) and pbl2/pbl3 mutant
(D,F) stage 8 embryos in which GFP-Actin was expressed in
mesodermal cells using the twist-GAL4 driver and visualised
with an anti-GFP antibody. (A) A UAS-GFP-Actin/twist-
GAL4 control embryo typical of the stage used in this
morphological analysis, between the first two waves of
mitosis in the mesoderm. (B) Cross-section of a control
embryo expressing GFP-Actin in mesodermal cells. Embryos
were oriented so that the leading mesodermal cells were
parallel to the plane of the microscope. The white line
indicates the plane of focus seen in C,D. The black line
indicates a deeper plane of focus seen in E,F.
(C,D) Projections of 1 m m optical sections of mid-stage 8
control (C) and pbl2/pbl3 (D) embryos showing the
morphology of migrating mesodermal cells at the leading
front. (C) Cells in a control embryo exhibit numerous
protrusions (arrows) in the direction of migration and appear
dissociated from each other. (D) Cells in a pbl2/pbl3 embryo
extend far fewer protrusions (arrow) and appear more tightly
adhered to their mesodermal neighbours. (E) Mesodermal
cells in a control embryo appear more rounded with
numerous intercellular gaps (arrowhead) present. (F) Cells in
a pbl2/pbl3 embryo appear more tightly packed and are less
rounded, with fewer intercellular gaps. Scale bars: 10 m m.
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development. Therefore, we investigated whether the GEF
function of PBL was required for mesodermal cell migration
and subsequent EVE-positive mesodermal cell formation. GEF
proteins are characterised by the presence of two domains at
their C terminus, a Dbl Homology (DH) and a Pleckstrin
Homology (PH) domain (Whitehead et al., 1997). Experiments
with a number of RhoGEFs have revealed that point mutations
and deletions within the DH domain significantly reduce the
exchange activity (Hart and Roberts, 1994; Liu et al., 1998;
Ron et al., 1991; Steven et al., 1998; Whitehead et al., 1995).
To address whether PBL was functioning as a RhoGEF in
mesodermal cell migration, we carried out two experiments. In
the first, a GEF mutated form of PBL, PBLD DH, in which amino
acids 497-549 within the DH domain are removed (Fig. 6I)
(Prokopenko et al., 1999), was expressed using a prd-GAL4
driver in a pbl mutant background. Expression of UAS-
pblD DH with prd-GAL4 in a pbl mutant background failed to
rescue the EVE-positive mesodermal cell formation phenotype
(Fig. 7A). The number of EVE-positive hemisegments in UAS-
pblD DH; pbl3/prd-GAL4, pbl2 embryos ranged from 0-18, with
a mean of 8.81±0.56 (n=61) (Fig. 3F,G). This number is similar
to the number observed in pbl2/pbl3 mutant embryos. We
conclude that the DH domain, and therefore the GEF activity,
is required for EVE-positive mesodermal cell formation.
The second approach used the pbl5 allele that contains a
single missense mutation in the most highly conserved region
(CR3) of the DH domain (Prokopenko et al., 1999). This point
mutation (valine to an aspartate at amino acid 531) has been
shown in other systems to significantly reduce the nucleotide
exchange activity of RhoGEFs (Liu et al., 1998; Prokopenko
Fig. 6. The defects in the mesodermal epithelial-mesenchymal
transition and the subsequent loss of the EVE-positive mesodermal
cells in pbl mutant embryos are independent of the cytokinetic defect.
(A,C,E,G) UAS-myc-pbl, pbl3/prd-GAL4, pbl2 embryos.
(B,D,F,H) UAS-pblD BRCT, pbl3/prd-GAL4, pbl2 embryos. (J-L) UAS-
GFP-Actin/twist-GAL4;UAS-pblD BRCT, pbl3/ pbl2 embryos. (A,B) Stage
11 embryos stained with anti-EVE and visualised using an alkaline
phosphatase assay. (C,D) Stage 14 embryos stained with anti-EVE and
visualised using fluorescence microscopy (white). (E-H) Anti-Spectrin
(green) and Hoechst 33258 DNA stain (blue). (G,H) Merge of the
fluorescent images above. Anti-EVE (red), Anti-Spectrin (green) and
Hoechst 33258 DNA stain (blue). (A,C,E,G) Expression of a wild-type
copy of a pbl cDNA in a pbl mutant background rescues the EVE-positive mesodermal cell formation and the cytokinetic defect. (A) EVE-
positive mesodermal cells are evident in embryos rescued with the wild-type pbl cDNA. (C,E,G) EVE-positive mesodermal cells are evident at
a higher magnification (C,G) and rescue of cytokinesis is seen in epidermal cells in alternating stripes corresponding to the prd-GAL4 induced
wild-type pbl expression (E,G). (D,F,H) Pbl D BRCT expression rescues the EVE-positive mesodermal cell defect (D,H) but fails to rescue the
cytokinetic phenotype in pbl mutants (F,H). Note that the EVE-positive mesodermal cells in C,D are imaged at a different focal plane than the
epidermis shown in E,F. (I) Schematic representations of the PBL constructs used in the EVE-positive hemisegment rescue assay.
(J-L) Expression of PBLD BRCT using the twist-GAL4 driver alters the cellular phenotype of GFP-Actin-expressing mesodermal cells. (J) Cells
extend more protrusions (arrows) in the direction of migration. (K) Cell bodies in the central mass of mesodermal cells appear more rounded
(compare with Fig. 5F) and intercellular gaps (arrowhead) are present. (L) Single optical slice of cells in J showing binucleate cells (arrowhead)
more clearly. Scale bars: 10 m m.
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et al., 1999). Consistent with this observation,
pbl5 homozygous mutant embryos exhibit a
strong cytokinetic phenotype. pbl5 homozygotes
were found to have few EVE-positive
hemisegments (Fig. 7B). The number of EVE-
positive hemisegments in pbl5/pbl5 mutant
embryos ranged from 0-14, with a mean of
4.5±0.37 (n=100) (Fig. 3C,G). This number is
even fewer than the number observed in
pbl2/pbl3 embryos.
We also examined the morphology of pbl5
mutant cells using F-actin staining and
mesodermal expression of GFP-Actin. The
results were comparable with pbl2/pbl3 embryos,
with mesodermal cells showing a similar range of
defects in spreading (Fig. 7C), morphology (Fig.
7E) and the extent of rounding/dissociation in the
body of the mesoderm (Fig. 7D). These results
show that the GEF activity of PBL is required for
the normal epithelial-mesenchymal transition,
migratory morphology and subsequent formation
of EVE-positive mesodermal cells.
The HTL/MAPK pathway is activated in
pebble mutant embryos
Heartless (HTL), a receptor tyrosine kinsase
(RTK) of the fibroblast growth factor receptor
(FGFR) subfamily is required for the mesoderm
EMT, where it is known to activate the conserved
Ras/MAP kinase pathway (reviewed by
Michelson et al., 1998). In htl mutant embryos,
mesodermal cells fail to dissociate from each
other following invagination and fail to migrate
dorsally (Beiman et al., 1996; Gisselbrecht et
al., 1996; Shishido et al., 1997). Mesoderm
migration also fails in embryos mutant for
three other genes: Downstream-of-FGFR (Dof)
(Vincent et al., 1998), Sugarless and Sulphateless (Lin et al.,
1999). In each case, the failure in mesoderm migration is
accompanied by a failure in the activation of the Ras1/MAPK
pathway (Lin et al., 1999; Vincent et al., 1998).
To investigate whether the pbl mutant phenotype was also
due to a failure in the activation of the HTL/MAPK pathway,
pbl mutant embryos were stained with an antibody directed
towards the dual phosphorylated form of MAP kinase (dp-
ERK) (Fig. 8) (Gabay et al., 1997a; Gabay et al., 1997b).
In wild-type embryos following gastrulation, dp-ERK is
expressed in the dorsalmost mesodermal cell rows on each
lateral surface of the embryo, a staining pattern that is HTL
dependent (Fig. 8A) (Gabay et al., 1997a; Gabay et al., 1997b).
In pbl mutant embryos, dp-ERK staining is seen in the
dorsalmost mesodermal cell rows similar to wild type (Fig. 8B).
This result shows that PBL function is not required for HTL-
dependent activation of the MAP kinase signalling pathway, and
that the mesoderm migration defect in pbl mutants is not due
to a failure in the activation of the MAPK pathway.
Discussion
The regulation and reorganisation of the actin cytoskeleton by
the Rho family of small GTPases is central to the control of
cell behaviour during embryonic development. We have shown
that Pebble (PBL), a putative exchange factor for Rho, is
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Fig. 7. The GEF function of PBL is required for the transition of the mesoderm from
an epithelium to migratory cells during Drosophila gastrulation. (A,B) The majority
of EVE-positive hemisegments fail to form in UAS-pblD DH; pbl3/prd-GAL4, pbl2 (A)
and pbl5/pbl5 embryos (B). (C) Cross-section of a stage 10 pbl5/pbl5 embryo stained
for F-actin showing a typical failure of the mesoderm to disaggregate and spread
dorsally. (D,E) UAS-GFP-Actin/twist-GAL4; pbl5/pbl5 embryos show similar
morphology to UAS-GFP-Actin/twist-GAL4; pbl2/pbl3 embryos (compare with Fig.
5D,F). Scale bars: 10 m m.
Fig. 8. PBL is not required for activation of the HTL/MAPK
pathway. Ventrolateral view of stage 8 embryos heterozygous (A)
and homozygous (B) for pbl2. Activation of the MAPK pathway,
visualised using an antibody specific to dpERK, the dual-
phosphorylated form of the MAPK (Gabay et al., 1997a; Gabay et
al., 1997b), is seen in the cells at the leading front (arrowheads) of
the mesoderm during dorsal migration.
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necessary for the transition of the Drosophila mesoderm from
an epithelial to a mesenchymal layer of cells following
ventral furrow formation. In wild-type mesodermal cells, this
transition involves a series of events that includes dissociation
of cells of the invaginated ventral furrow, settlement onto the
ventral ectoderm and spreading of the cells dorsally to the edge
of the ectoderm (reviewed by Leptin, 1999). In pbl mutant
embryos, the initial loss of epithelial structure occurs, but the
cells remain more tightly adhered to their neighbours and
extend very few protrusions, failing to disperse and to migrate
dorsally.
The Pebble RhoGEF is an essential component of an
intracellular signalling pathway required for acto-myosin
reorganisation during cytokinesis (Hime and Saint, 1992;
Lehner, 1992; Prokopenko et al., 1999). Although cell division
occurs during the epithelial-mesenchymal transition of
mesodermal cells, there appears to be no causal connection
between cell division and mesodermal cell behaviour. Cells in
string (stg) mutant embryos, for example, arrest in G2 phase
of cycle 14 (Edgar and O’Farrell, 1989) immediately prior to
the stage at which the cytokinetic defect becomes evident in
pbl mutant embryos. However, mesoderm spreading and
subsequent EVE-positive mesodermal cell formation occurs in
string (stg) mutant embryos (Carmena et al., 1998; Leptin and
Grunewald, 1990), while it is aberrant in pbl mutant embryos.
It is true that the nature of the cell cycle arrest in these two
mutants is very different. stg mutant cells are mononucleate
and arrested in G2 phase, while pbl mutant cells become
binucleate, then multinucleate, undergoing apparently normal
mitotic divisions without cytokinesis (Hime and Saint, 1992;
Lehner, 1992). However, a causative role for cytokinesis failure
in the mesoderm phenotype was ruled out by the observation
that expression of a site-directed mutant form of pbl that
lacks the N-terminal BRCT domains rescues the mesoderm
phenotype but not the cytokinetic phenotype of pbl. We
conclude, therefore, that the pbl mesodermal function appears
to be distinct from its cytokinesis function.
It is well documented that mesoderm development, in
particular the invagination, dissociation and migration of
mesodermal cells, requires significant cytoskeletal mediated
cell shape changes (Leptin and Grunewald, 1990). The first
regulatory components implicated in these processes were
RHO1 and the RHO1 activator, RhoGEF2, which are required
for ventral furrow formation (Barrett et al., 1997; Hacker and
Perrimon, 1998). However, very little is known about the
control of the cytoskeleton in the dispersion and dorsal
migration of mesodermal cells that follows ventral furrow
formation.
Two lines of evidence suggest that PBL is required to
reorganise the actin cytoskeleton in order for the cells to
dissociate and migrate. First, we observed that the protrusions
normally found at the leading edge of the dispersing ventral
furrow cells were greatly reduced in pbl mutant embryos.
Second, we found that the PBL RhoGEF activity is required
for this process. We are yet to determine which Rho family
small GTPase is activated by PBL in mesodermal tissues.
Genetic analysis indicates that PBL acts in vivo as a GEF for
RHO1 during cytokinesis (O’Keefe et al., 2001; Prokopenko
et al., 1999). Rho activity is generally thought to stimulate
acto-myosin contractile activity or to promote stress fibre
formation in association with cell-cell or cell-matrix
connections (Hall, 1998; Omelchenko et al., 2002; Ridley and
Hall, 1992). Our observations that protrusions are greatly
reduced in pbl mutant embryos, is more reminiscent of a loss
of Rac and/or CDC42 activity than Rho activity. It is possible
that PBL could be modified to target Rac and/or CDC42 in
migrating mesodermal cells.
In addition to a reduction in the number of protrusive
structures, pbl mutant mesodermal cells are less rounded and
appear more tightly adhered to each other. The epithelial to
mesenchymal transition during mesoderm development is
known to involve a reduction in levels of DE-Cadherin (Oda et
al., 1998). It is possible therefore, that PBL may play a role in
reducing adhesion between mesodermal cells. In vertebrates,
Rho family GTPases are known to positively regulate cadherin-
based adhesion (Braga et al., 1997; Fukata et al., 1999).
Their role in Drosophila is less clear. During tracheal
morphogenesis, RAC1 appears to be required to negatively
regulate cadherin adhesion to allow cell rearrangements to
occur (Chihara et al., 2003). RHO1, however, appears to play
a positive role. Zygotic loss of RHO1 causes mislocalisation
of DE-Cadherin (Magie et al., 2002) and expression of
dominant negative RHO1 can reduce DE-Cadherin levels and
cell-cell adhesion (Bloor and Kiehart, 2002). However,
overexpression of RHO1 in the wing imaginal disks can induce
a type of EMT in which cells drop out of the epithelium,
express lower levels of DE-Cadherin and can become displaced
from their neighbours (Speck et al., 2003). One possibility
therefore, is that PBL is acting through RHO1, or perhaps
RAC1, to reduce adhesion between mesodermal cells allowing
them to spread out over the epidermis. The delamination of
neural crest cells from the neural tube, another example of an
epithelial-mesenchymal transition, has been found to require
RhoB (Liu and Jessell, 1998). It is possible therefore, that these
biologically and evolutionarily different processes may be
driven by related mechanisms.
PBL joins a small set of factors that have been shown to be
required for mesodermal cell behaviour immediately following
ventral furrow formation. These include Heartless (HTL), a
Drosophila FGF Receptor homologue (Beiman et al., 1996;
Gisselbrecht et al., 1996; Shishido et al., 1997), the Sugarless
(SGL) and Sulfateless (SFL) enzymes required for the
synthesis of extracellular glycosaminoglycans that facilitate
FGF signalling (Lin et al., 1999), and intracellular factors
acting downstream of HTL, including Downstream of FGFR
(DOF) and Ras1 (Michelson et al., 1998; Vincent et al., 1998).
PBL is unique in not being required for activation of the
HTL/MAPK pathway. Whether PBL acts downstream of this
pathway or in a parallel pathway also required for the
mesoderm EMT is yet to be determined.
In conclusion, our studies identify a novel, PBL-mediated
mechanism required for the epithelial to mesenchymal
transition of mesodermal cells of the ventral furrow. The
epithelial-to-mesenchymal transition is an important feature of
animal development and it is also central to the spread of
cancers. It will therefore be important to determine whether
orthologues of PBL, such as the mammalian proto-oncogene
ECT2, are playing roles in related processes.
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